• Users Online: 122
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

A focus on CXCR4 in Alzheimer's disease

Li Hongyan, Wang Rong

Year : 2017| Volume: 3| Issue : 4 | Page no: 199-203

   This article has been cited by
 
1 Research progress of the CXCR4 mechanism in Alzheimer's disease
Qiu-Lin Wang, Chang-Le Fang, Xue-Yan Huang, Lu-Lu Xue
Ibrain. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 A Comprehensive Investigation of Molecular Signatures and Pathways Linking Alzheimer’s Disease and Epilepsy via Bioinformatic Approaches
Jiao Wu, Shu Zhu, Chenyang Zhao, Xiaoxue Xu
Current Alzheimer Research. 2022; 19(2): 146
[Pubmed]  [Google Scholar] [DOI]
3 Ligand-based Modeling of CXC Chemokine Receptor 4 and Identification of Inhibitors of Novel Chemotypes as Potential Leads towards New Anti- COVID-19 Treatments
Safa Daoud, Mutasem Taha
Medicinal Chemistry. 2022; 18(8): 871
[Pubmed]  [Google Scholar] [DOI]
4 Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Nerea Requena-Ocaña, María Flores-Lopez, Esther Papaseit, Nuria García-Marchena, Juan Jesús Ruiz, Jesús Ortega-Pinazo, Antonia Serrano, Francisco Javier Pavón-Morón, Magí Farré, Juan Suarez, Fernando Rodríguez de Fonseca, Pedro Araos
Biomedicines. 2022; 10(5): 947
[Pubmed]  [Google Scholar] [DOI]
5 CXCR4 inhibition with AMD3100 attenuates amphetamine induced locomotor activity in adolescent Long Evans male rats
Briana Mason,Corey Calhoun,Victoria Woytowicz,Latifa Pina,Roshninder Kanda,Curtis Dunn,Antonio Alves,S. Tiffany Donaldson,Pavel I. Ortinski
PLOS ONE. 2021; 16(3): e0247707
[Pubmed]  [Google Scholar] [DOI]
6 PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer’s Disease and Multiple Sclerosis
Fan Chen, Yan Zhang, Longcai Wang, Tao Wang, Zhifa Han, Haihua Zhang, Shan Gao, Yang Hu, Guiyou Liu
Journal of Alzheimer's Disease. 2021; 80(1): 71
[Pubmed]  [Google Scholar] [DOI]
7 PathwayMultiomics: An R Package for Efficient Integrative Analysis of Multi-Omics Datasets With Matched or Un-matched Samples
Gabriel J. Odom, Antonio Colaprico, Tiago C. Silva, X. Steven Chen, Lily Wang
Frontiers in Genetics. 2021; 12
[Pubmed]  [Google Scholar] [DOI]
8 At the bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer
Gary D Luker,Jinming Yang,Ann Richmond,Stefania Scala,Claudio Festuccia,Margret Schottelius,Hans-Jürgen Wester,Johann Zimmermann
Journal of Leukocyte Biology. 2020;
[Pubmed]  [Google Scholar] [DOI]
9 Postsynaptic damage and microglial activation in AD patients could be linked CXCR4/CXCL12 expression levels
Cristina Sanfilippo, Paola Castrogiovanni, Rosa Imbesi, Giuseppe Nunnari, Michelino Di Rosa
Brain Research. 2020; 1749: 147127
[Pubmed]  [Google Scholar] [DOI]
10 Insights from RNA-Seq analysis of Alzheimeræs data suggest upregulation of GPCRs
Amit Chaudhary,Shikha Kushwah,Neha Shree Maurya,Ashutosh Mani
Gene Reports. 2020; 21: 100921
[Pubmed]  [Google Scholar] [DOI]
11 Epigenetic effects of paternal cocaine on reward stimulus behavior and accumbens gene expression in mice
Alexandra M. Yaw,Rebecca A. Prosser,Piet C. Jones,Benjamin J. Garcia,Daniel A. Jacobson,J. David Glass
Behavioural Brain Research. 2019; 367: 68
[Pubmed]  [Google Scholar] [DOI]
12 Data-Driven Analysis of Age, Sex, and Tissue Effects on Gene Expression Variability in Alzheimeræs Disease
Lavida R. K. Brooks,George I. Mias
Frontiers in Neuroscience. 2019; 13
[Pubmed]  [Google Scholar] [DOI]
13 Patent highlights February–March 2019
Hermann AM Mucke
Pharmaceutical Patent Analyst. 2019;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article